Gossamer Bio, Inc.
Gossamer Bio, Inc. (GOSS) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
GOSS · net income · updated Jun 8, 2026
Core profitability metrics
GOSS · net income · margin · TTM · CAGRNet income was −$170.4M for FY2025 (fiscal year ending 2025-12-31), down 201.4% year-over-year. Net profit margin was -351.5%.
Annual net income history
▸ FMP /income-statement · Annual · GOSS net income history · GOSS profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Gossamer Bio, Inc. (GOSS) reported net income of −$170.4M for FY2025 (fiscal year ending 2025-12-31), down 201.4% year-over-year. The net profit margin was -351.5% — meaning the company kept $-3.51 of every dollar of revenue as profit.
Gossamer Bio, Inc. has not yet achieved annual profitability based on available data (10 fiscal years). The company has reported net losses across all available periods.
Gossamer Bio, Inc.'s net profit margin was -351.5% for FY2025, based on the latest annual results.
Investors sometimes search for "Gossamer Bio, Inc. net worth" — the company's market capitalization is a separate figure from GOSS net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
GOSS net income · 4 questionsGossamer Bio, Inc. is not currently profitable on an annual basis. The company reported a net loss of $170.4M for FY2025.
▸ Source: FMP /income-statement · GAAP · Gossamer Bio, Inc. · Gossamer Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026